Donald Bergstrom

Donald Bergstrom currently serves as a Board Member for Cellectis and Fusion Pharmaceuticals, as well as the President of Research and Development at Relay Therapeutics. Prior experience includes the role of Chief Medical Officer at Mersana Therapeutics and Global Head of Translational Medicine at Sanofi Oncology, where efforts were concentrated on enhancing oncology drug discovery and development processes. Additional positions held include Director of Experimental Medicine Oncology at Merck and a post-doctoral fellowship at FHCRC. Donald Bergstrom's education includes an MD PhD in Pathology and Medicine from the University of Washington and a BA in Biophysics and English from The Johns Hopkins University.